Drugs / DTaP/IPV/Hib vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02482636 | Aug 2015 → Nov 2017 | infectious disease | University of Oxford | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DTaP/IPV/Hib vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02482636 ↗ |
| Modality | Vaccine | “DTaP/IPV/Hib vaccine IM 0.5ml at 2, 3 and 4 months” NCT02482636 ↗ |
| Route | Intramuscular | “DTaP/IPV/Hib vaccine IM 0.5ml at 2, 3 and 4 months” NCT02482636 ↗ |